SPR Therapeutics

SPR Therapeutics, a spinoff of NDI Medical, has developed a proprietary peripheral nerve stimulation platform to address a critical unmet need for non-narcotic, less invasive, reversible, and cost effective treatments for acute, post-operative and chronic pain. The company is sponsoring clinical studies to evaluate this technology in multiple high-potential pain indications.

Funding: NDI Healthcare Fund, JumpStart, Grants, Public Square Partners, GLIDE

Stage: Clinical

News: SPR Therapeutics Raises $25 Million